BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6033789)

  • 1. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Dollinger MR; Burchenal JH; Kreis W; Fox JJ
    Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds.
    Renis HE
    Cancer Res; 1970 Jan; 30(1):189-94. PubMed ID: 5466741
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
    Schrecker AW
    Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
    [No Abstract]   [Full Text] [Related]  

  • 6. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD; Grindey GB; Kline I; Waravdekar VS
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.
    Lauzon GJ; Paterson AR; Belch AW
    Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
    Grindey GB; Saslaw LD; Waravdekar VS
    Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleosides. 48. Synthesis of 1-(5-deoxy-beta-D-arabinosyl)cytosine and related compounds.
    Falco EA; Fox JJ
    J Med Chem; 1968 Jan; 11(1):148-51. PubMed ID: 5637160
    [No Abstract]   [Full Text] [Related]  

  • 10. The teratogenic effect of 1-beta-D-arabinofuranosylcytosine in the rat. Protection by deoxycytidine.
    Chaube S; Kreis W; Uchida K; Murphy ML
    Biochem Pharmacol; 1968 Jul; 17(7):1213-6. PubMed ID: 5659770
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
    Hoshi A; Kanzawa F; Kuretani K; Kanai T; Ichino M
    Biochem Pharmacol; 1973 Nov; 22(22):2829-34. PubMed ID: 4761553
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on a new mechanism of resistance of L5178Y murine leukemia cells to cytosine arabinoside.
    Momparler RL; Chu MY; Fischer GA
    Biochim Biophys Acta; 1968 Jul; 161(2):481-93. PubMed ID: 4174433
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleosides. XLV. 1-alpha-L-aldo-pentofuranosylpyrimidines.
    Yamaoka N; Otter BA; Fox JJ
    J Med Chem; 1968 Jan; 11(1):55-9. PubMed ID: 5637190
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.
    Graham FL; Whitmore GF
    Cancer Res; 1970 Nov; 30(11):2627-35. PubMed ID: 5530557
    [No Abstract]   [Full Text] [Related]  

  • 15. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.
    Khwaja TA; Kigwana LJ; Mian AM
    Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1972 Mar; 48(3):685-95. PubMed ID: 5058968
    [No Abstract]   [Full Text] [Related]  

  • 17. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
    Durham JP; Ives DH
    Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509
    [No Abstract]   [Full Text] [Related]  

  • 18. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).
    Chu MY; Fischer GA
    Biochem Pharmacol; 1968 May; 17(5):753-67. PubMed ID: 5689802
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytidine 3',5'-monophosphate (cyclic CMP). II. Initiation of leukemia L-1210 cell growth in vitro.
    Bloch A; Dutschman G; Maue R
    Biochem Biophys Res Commun; 1974 Aug; 59(3):955-9. PubMed ID: 4369899
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.